What are the methods for treating lung cancer? The most effective treatment methods for lung cancer

At present, the treatment for lung cancer is basically the same as that for most other malignant tumors. Surgery is the most ideal, but surgery is often only suitable for patients in the early and middle stages. For patients in the late stages, chemotherapy is often used to prolong the patient's life and improve the quality of life. The following is an introduction to the treatment of lung cancer:

Treatments for lung cancer:

Chemotherapy

In the past two decades, tumor chemotherapy has developed rapidly and has been widely used. The efficacy of chemotherapy on small cell lung cancer is relatively certain, whether in the early or late stages, and there are even a few reports of radical cure; it also has a certain effect on non-small cell lung cancer, but it is only palliative and the effect needs to be further improved. In recent years, the role of chemotherapy in lung cancer is no longer limited to patients with advanced lung cancer who cannot undergo surgery, but is often included in the comprehensive treatment plan for lung cancer as a systemic treatment. Chemotherapy will inhibit the bone marrow hematopoietic system, mainly the decrease of white blood cells and platelets. It is best to combine it with traditional Chinese medicine and immunotherapy.

(I) Chemotherapy for small cell lung cancer Due to the biological characteristics of small cell lung cancer, it is generally recognized that chemotherapy should be the first choice except for a few patients with sufficient evidence showing no intrathoracic lymph node metastasis.

1. Indications

(1) Patients with small cell lung cancer confirmed by pathology or cytology;

(2) KS score is 50-60 points or above;

(3) Those with an expected survival time of more than one month

(4) Persons aged ≤70 years.

2. Contraindications

(1) Elderly or cachectic patients;

(2) Those with severe heart, liver and kidney dysfunction;

(3) Poor bone marrow function with white blood cells below 3×10^9/L and platelets below 80×10^9/L (direct count);

(4) There are complications and infection, fever, bleeding tendency, etc.

(II) Chemotherapy for non-small cell lung cancer Although there are many effective drugs for non-small cell lung cancer, the efficacy is low and complete remission is rarely achieved.

1. Indications:

(1) Patients with stage III disease confirmed by pathology or cytology to have squamous cell carcinoma, adenocarcinoma or large cell carcinoma who are not suitable for surgery, and patients with postoperative recurrence and metastasis or stage III disease who are not suitable for surgery for other reasons;

(2) Patients with the following conditions after surgical exploration and pathological examination: ① residual lesions; ② intrathoracic lymph node metastasis; ③ cancer thrombi in lymphatic vessels or thrombi; ④ poorly differentiated cancer;

(3) Patients with pleural or pericardial effusion require local chemotherapy.

2. Contraindications: Same as small cell carcinoma.

Radiation therapy

(I) Treatment principles Radiotherapy is the best for small cell carcinoma, followed by squamous cell carcinoma, and the worst for adenocarcinoma. However, small cell carcinoma is prone to metastasis, so large-area irregular irradiation is often used. The irradiation area should include the primary lesion, the supraclavicular area on both sides of the mediastinum, and even the liver and brain, and should be supplemented with drug therapy. Squamous cell carcinoma is moderately sensitive to radiation, and the lesions are mainly local invasions, and metastasis is relatively slow, so radical treatment is often used. Adenocarcinoma is less sensitive to radiation and is prone to blood metastasis, so simple radiotherapy is rarely used.

(ii) There are many radiation complications, which may even cause partial functional loss; for patients with advanced tumors, the effect of radiotherapy is not perfect. At the same time, patients with poor physical condition and older age are not suitable for radiotherapy.

(III) Indications for radiotherapy are divided into radical treatment, palliative treatment, preoperative radiotherapy, postoperative radiotherapy and intracavitary radiotherapy according to the purpose of treatment.

Radical treatment

1. Palliative treatment: Its purpose varies greatly. There are palliative treatments that are close to radical treatment to relieve patients' pain, prolong life, and improve quality of life; there are also palliative treatments that only relieve symptoms of advanced patients and even cause comfort, such as pain, paralysis, coma, shortness of breath, and bleeding. The number of irradiation times for palliative treatment can range from a few times to dozens of times, depending on the specific situation and equipment conditions. However, the principle must be not to increase the patient's pain. If there is a large radiation reaction or a decrease in the KS score during treatment, the treatment plan can be modified as appropriate.

2. Preoperative radiotherapy: It aims to improve the surgical resection rate and reduce the risk of tumor spread during surgery. For patients who are estimated to have no difficulty in surgical resection, high-dose, less-fractionated radiotherapy can be used before surgery; if the tumor is huge or has external invasion, and it is estimated that surgical resection will be difficult, conventional fractionated radiotherapy can be used. The time between radiotherapy and surgery is generally about 50 days, and the longest time should not exceed three months.

3. Postoperative radiotherapy: It is used for cases where the preoperative estimate is insufficient and the tumor is not completely removed during surgery. Silver clips should be placed on the local residual lesions to facilitate accurate positioning during radiotherapy.

4. Intracavitary short-distance radiotherapy: It is suitable for cancer lesions confined to large bronchi. Afterloading technology can be used to place the catheter at the bronchial lesions through a fiberoptic bronchoscope. Iridium (192Ir) can be used for short-distance radiotherapy in combination with external irradiation to improve the treatment effect.

Surgical treatment of lung cancer

The treatment of lung cancer should be based on surgery or strive for surgery except for stages IIIb and IV, and combined treatment with radiotherapy, chemotherapy and immunotherapy should be added according to different stages and pathological tissue types.

Regarding the survival period after lung cancer surgery, domestic reports have shown that the three-year survival rate is about 40% to 60%; the five-year survival rate is about 22% to 44%; and the surgical mortality rate is below 3%.

(I) Surgical indications

People with the following conditions can generally undergo surgical treatment:

1. No distant metastasis, including solid organs such as liver, brain, adrenal glands, bones, extrathoracic lymph nodes, etc.;

2. The cancerous tissue has not invaded or spread to adjacent organs or tissues in the chest, such as the aorta, superior vena cava, esophagus, and cancerous pleural effusion;

3. Those without severe cardiopulmonary dysfunction or recent onset of angina;

4. Those without severe liver or kidney diseases and severe diabetes.

Patients with the following conditions should generally undergo surgery with caution or require further examination and treatment:

(1) Elderly people with poor cardiopulmonary function;

(2) Except for stage I, small cell lung cancer should be treated with chemotherapy or radiotherapy first, and then determine whether it can be treated surgically;

(3) In addition to the primary lesion, X-ray findings also reveal several suspicious metastases in the mediastinum.

At present, the academic community has relaxed the indications for surgical treatment of lung cancer. For some patients with invasion of the major thoracic blood vessels and distant isolated metastases, as long as their physical conditions permit, some scholars believe that surgery can be performed, and relevant exploration and research have been conducted.

(II) Indications for exploratory thoracotomy

Patients with no contraindications to surgery and who are clearly diagnosed with lung cancer or highly suspected of having lung cancer can choose a surgical procedure based on the specific situation. If the lesion is found during the operation to be beyond the resectable range but the primary cancer is still resectable, the primary lesion should be removed. This is called reduction surgery. However, in principle, a complete lung resection is not performed to allow for other postoperative auxiliary treatments.

3. Choice of surgical procedure for lung cancer

According to the 1985 international lung cancer staging system, patients with stage I, II, and III lung cancer who do not have surgical contraindications can be treated with surgery. The principle of surgical resection is to completely remove the primary lesion and the lymph nodes in the chest that may have metastasized, and preserve normal lung tissue as much as possible. Pneumonectomy should be performed with caution.

1. Local resection: refers to wedge-shaped cancer block resection and lung segment resection. For patients with very small primary cancer, the elderly and the weak, with poor lung function, or with well-differentiated cancer and low malignancy, local lung resection can be considered.

2. Lobectomy: For isolated peripheral lung cancer, limited to one lobe without obvious lymph node enlargement, lobectomy can be performed. If the tumor involves two lobes or the middle bronchus, upper middle lobe or lower middle lobe lung resection can be performed;

3. Sleeve lobectomy: This procedure is mostly used for lung cancer in the right upper and middle lobes. If the tumor is located in the lobar bronchus and involves the opening of the lobar bronchus, sleeve lobectomy can be performed.

4. Pneumonectomy: When the lesions are extensive and cannot be removed by the above methods, pneumonectomy can be carefully considered;

5. Carina resection and reconstruction: When the tumor exceeds the main bronchus and involves the carina or tracheal side wall but does not exceed 2 cm: ① Carina resection and reconstruction or sleeve pneumonectomy can be performed; ② If one lobe of the lung can be retained, try to retain it. The surgical method can be determined according to the situation at the time.

4. Surgical treatment of recurrent or recurrent lung cancer

1. Although surgery can remove the tumor, there may still be residual cancer, regional lymph node metastasis, or cancer thrombus in the blood vessels, etc., and the chance of recurrence and metastasis is very high. Treatment of multiple primary lung cancer: For patients diagnosed with multiple primary lung cancer, the treatment principle is to treat the second primary lesion.

2. Treatment of recurrent lung cancer: Recurrent lung cancer refers to the recurrence of cancer foci within the original surgical scar or intrathoracic cancer foci related to the primary foci. The treatment principle should be to determine the scope of surgery based on the patient's cardiopulmonary function and whether the tumor can be removed.

The symptoms of lung cancer are first local symptoms. For example, patients will experience coughing, which is one of the most common symptoms. About 35% of patients will experience it and have sputum. In severe cases, there will be blood in the sputum. This is generally advanced lung cancer, not early stage.